Efficacy in Pigs of Inactivated and Live Attenuated Influenza Virus Vaccines against Infection and Transmission of an Emerging H3N2 Similar to the 2011-2012 H3N2v

Journal of Virology

Volumn 87, Issue 17, 2013, Pages 9895-9903

  Loving, Crystal L ^a   Lager, Kelly M ^a   Vincent, Amy L ^a   Brockmeier, Susan L ^a   Gauger, Phillip C ^b   Anderson, Tavis K ^a   Kitikoon, Pravina ^a   Perez, Daniel R ^c   Kehrli Jr , Marcus E ^a  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

^b IOWA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUSURE XP; INFLUENZA VACCINE; MAXIVAC EXCELL 5 0; PNEUMOSTAR SIV; UNCLASSIFIED DRUG;

AGRICULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HEMAGGLUTINATION INHIBITION; IMMUNITY; INFECTION CONTROL; INFLUENZA A (H3N2); INFLUENZA VACCINATION; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H3N2V; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPEATED DRUG DOSE; SWINE; VIRUS DETECTION; VIRUS SHEDDING; VIRUS STRAIN; VIRUS TRANSMISSION; ZOONOSIS;

ANIMALS; ANTIBODIES, VIRAL; COMMUNICABLE DISEASES, EMERGING; GENES, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE INFECTIONS; PHYLOGENY; REASSORTANT VIRUSES; SUS SCROFA; SWINE; SWINE DISEASES; VACCINES, ATTENUATED; VACCINES, INACTIVATED; VIRUS SHEDDING;

EID: 84883279693     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01038-13     Document Type: Article

References (40)

1. Centers for Disease Control and Prevention (CDC). 2011. Swine-origin influenza A (H3N2) virus infection in two children-Indiana and Pennsylvania, July-August 2011. MMWR Morb. Mortal. Wkly. Rep. 60:1213-1215.
2. Brockwell-Staats C, Webster RG, Webby RJ. 2009. Diversity of influenza viruses in swine and the emergence of a novel human pandemic influenza A (H1N1). Influenza Other Respi. Viruses 3:207-213.
3. Ducatez MF, Hause B, Stigger-Rosser E, Darnell D, Corzo C, Juleen K, Simonson R, Brockwell-Staats C, Rubrum A, Wang D, Webb A, Crumpton JC, Lowe J, Gramer M, Webby RJ. 2011. Multiple reassortment between pandemic (H1N1) 2009 and endemic influenza viruses in pigs, United States. Emerg. Infect. Dis. 17:1624-1629.
4. Liu Q, Ma J, Liu H, Qi W, Anderson J, Henry SC, Hesse RA, Richt JA, Ma W. 2012. Emergence of novel reassortant H3N2 swine influenza viruses with the 2009 pandemic H1N1 genes in the United States. Arch. Virol. 157:555-562.
5. Richt JA, Lager KM, Janke BH, Woods RD, Webster RG, Webby RJ. 2003. Pathogenic and antigenic properties of phylogenetically distinct reassortant H3N2 swine influenza viruses cocirculating in the United States. J. Clin. Microbiol. 41:3198-3205.
6. Webby RJ, Rossow K, Erickson G, Sims Y, Webster R. 2004. Multiple lineages of antigenically and genetically diverse influenza A virus cocirculate in the United States swine population. Virus Res. 103:67-73.
7. Olsen CW, Karasin AI, Carman S, Li Y, Bastien N, Ojkic D, Alves D, Charbonneau G, Henning BM, Low DE, Burton L, Broukhanski G. 2006. Triple reassortant H3N2 influenza A viruses, Canada, 2005. Emerg. Infect. Dis. 12:1132-1135.
8. Lorusso A, Vincent AL, Harland ML, Alt D, Bayles DO, Swenson SL, Gramer MR, Russell CA, Smith DJ, Lager KM, Lewis NS. 2011. Genetic and antigenic characterization of H1 influenza viruses from United States swine from 2008. J. Gen. Virol. 92:919-930.
9. Vincent AL, Ma W, Lager KM, Janke BM, Richt JA. 2008. Swine influenza viruses: a North American perspective. Adv. Virus Res. 72:127- 154.
10. Nelson MI, Detmer SE, Wentworth DE, Tan Y, Schwartzbard A, Halpin RA, Stockwell TB, Lin X, Vincent AL, Gramer MR, Holmes EC. 2012. Genomic reassortment of influenza A virus in North American swine, 1998-2011. J. Gen. Virol. 93:2584-2589.
11. Nelson MI, Vincent AL, Kitikoon P, Holmes EC, Gramer MR. 2012. Evolution of novel reassortant A/H3N2 influenza viruses in North American swine and humans, 2009-2011. J. Virol. 86:8872-8878.
12. Kappes MA, Sandbulte MR, Platt R, Wang C, Lager KM, Henningson JN, Lorusso A, Vincent AL, Loving CL, Roth JA, Kehrli ME, Jr. 2012. Vaccination with NS1-truncated H3N2 swine influenza virus primes T cells and confers cross-protection against an H1N1 heterosubtypic challenge in pigs. Vaccine 30:280-288.
13. Vincent AL, Ma W, Lager KM, Richt JA, Janke BH, Sandbulte MR, Gauger PC, Loving CL, Webby RJ, Garcia-Sastre A. 2012. Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccineassociated enhanced respiratory disease. J. Virol. 86:10597-10605.
14. Babiuk S, Masic A, Graham J, Neufeld J, van der Loop M, Copps J, Berhane Y, Pasick J, Potter A, Babiuk LA, Weingartl H, Zhou Y. 2011. An elastase-dependent attenuated heterologous swine influenza virus protects against pandemic H1N1 2009 influenza challenge in swine. Vaccine 29:3118-3123.
15. Solórzano A, Ye J, Perez DR. 2010. Alternative live-attenuated influenza vaccines based on modifications in the polymerase genes protect against epidemic and pandemic flu. J. Virol. 84:4587-4596.
16. Kitikoon P, Vincent AL, Gauger PC, Schlink SN, Bayles DO, Gramer MR, Darnell D, Webby RJ, Lager KM, Swenson SL, Klimov A. 2012. Pathogenicity and transmission in pigs of the novel A(H3N2)v influenza virus isolated from humans and characterization of swine H3N2 viruses isolated in 2010-2011. J. Virol. 86:6804-6814.
17. Edgar RC. 2004. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32:1792-1797.
18. Stamatakis A. 2006. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics 22:2688-2690.
19. Loving CL, Vincent AL, Pena L, Perez DR. 2012. Heightened adaptive immune responses following vaccination with a temperature-sensitive, live-attenuated influenza virus compared to adjuvanted, wholeinactivated virus in pigs. Vaccine 30:5830-5838.
20. Pena L, Vincent AL, Ye J, Ciacci-Zanella JR, Angel M, Lorusso A, Gauger PC, Janke BH, Loving CL, Perez DR. 2011. Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses. J. Virol. 85:456-469.
21. Vincent AL, Ma W, Lager KM, Janke BH, Webby RJ, Garcia-Sastre A, Richt JA. 2007. Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine. Vaccine 25:7999-8009.
22. Solórzano A, Webby RJ, Lager KM, Janke BH, Garcia-Sastre A, Richt JA. 2005. Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs. J. Virol. 79:7535- 7543.
23. Halbur PG, Paul PS, Frey ML, Landgraf J, Eernisse K, Meng XJ, Lum MA, Andrews JJ, Rathje JA. 1995. Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus. Vet. Pathol. 32:648-660.
24. Gauger PC, Vincent AL, Loving CL, Henningson JN, Lager KM, Janke BH, Kehrli ME, Jr, Roth JA. 2012. Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus. Vet. Pathol. 49:900-912.
25. Kitikoon P, Nilubol D, Erickson BJ, Janke BH, Hoover TC, Sornsen SA, Thacker EL. 2006. The immune response and maternal antibody inter- ference to a heterologous H1N1 swine influenza virus infection following vaccination. Vet. Immunol. Immunopathol. 112:117-128.
26. Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:493-497.
27. Bowman AS, Nolting JM, Nelson SW, Slemons RD. 2012. Subclinical influenza virus A infections in pigs exhibited at agricultural fairs, Ohio, USA, 2009-2011. Emerg. Infect. Dis. 18:1945-1950.
28. Kitikoon P, Nelson MI, Killian ML, Anderson TK, Koster L, Culhane MR, Vincent AL. 13 March 2013. Genotype patterns of contemporary reassorted H3N2 virus in U.S. swine. J. Gen. Virol. (Epub ahead of print.) doi:10.1099/vir.0.051839-0.
29. Centers for Disease Control and Prevention (CDC). 2012. Antibodies cross-reactive to influenza A (H3N2) variant virus and impact of 2010- 2011 seasonal influenza vaccine on cross-reactive antibodies-United States. MMWR Morb. Mortal. Wkly. Rep. 61, 237-241.
30. Shu B, Garten R, Emery S, Balish A, Cooper L, Sessions W, Deyde V, Smith C, Berman L, Klimov A, Lindstrom S, Xu X. 2012. Genetic analysis and antigenic characterization of swine origin influenza viruses isolated from humans in the United States, 1990-2010. Virology 422:151- 160.
31. Lina B, Bouscambert M, Enouf V, Rousset D, Valette M, van der Werf S. 2011. S-OtrH3N2 viruses: use of sequence data for description of the molecular characteristics of the viruses and their relatedness to previously circulating H3N2 human viruses. Euro Surveill. 16:20039. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId 20039.
32. Skowronski DM, Janjua NZ, De Serres G, Purych D, Gilca V, Scheifele DW, Dionne M, Sabaiduc S, Gardy JL, Li G, Bastien N, Petric M, Boivin G, Li Y. 2012. Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v). J. Infect. Dis. 206:1852-1861.
33. Houser KV, Katz JM, Tumpey TM. 2013. Seasonal trivalent inactivated influenza vaccine does not protect against newly emerging variants of influenza A (H3N2v) virus in ferrets. J. Virol. 87:1261-1263.
34. Van Reeth K, Ma W. 2013. Swine influenza virus vaccines: to change or not to change-that's the question. Curr. Top. Microbiol. Immunol. 370: 173-200.
35. Masic A, Lu X, Li J, Mutwiri GK, Babiuk LA, Brown EG, Zhou Y. 2010. Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs. Vaccine 28:7098-7108.
36. Romagosa A, Allerson M, Gramer M, Joo HS, Deen J, Detmer S, Torremorell M. 2011. Vaccination of influenza a virus decreases transmission rates in pigs. Vet. Res. 42:120.
37. Hammitt LL, Bartlett JP, Li S, Rahkola J, Lang N, Janoff EN, Levin MJ, Weinberg A. 2009. Kinetics of viral shedding and immune responses in adults following administration of cold-adapted influenza vaccine. Vaccine 27:7359-7366.
38. Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, Bernstein DI, Hayden FG, Kotloff K, Zangwill K, Iacuzio D, Wolff M. 1998. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N. Engl. J. Med. 338:1405-1412.
39. Sun K, Ye J, Perez DR, Metzger DW. 2011. Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections. J. Immunol. 186:987-993.
40. Tosh PK, Boyce TG, Poland GA. 2008. Flu myths: dispelling the myths associated with live attenuated influenza vaccine. Mayo Clin. Proc. 83:77- 84.